These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 476619

  • 1. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
    Momparler RL, Veselý J, Momparler LF, Rivard GE.
    Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
    [Abstract] [Full Text] [Related]

  • 2. Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.
    Momparler RL, Momparler LF.
    Cancer Chemother Pharmacol; 1989 Oct; 25(1):51-4. PubMed ID: 2480188
    [Abstract] [Full Text] [Related]

  • 3. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR, Campbell J, Rustum YM.
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [Abstract] [Full Text] [Related]

  • 4. 3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.
    Raynal NJ, Momparler LF, Rivard GE, Momparler RL.
    Leuk Res; 2011 Jan; 35(1):110-8. PubMed ID: 20510451
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2'-deoxycytidine as a possible mechanism of chemotherapeutic action.
    Wilson VL, Jones PA, Momparler RL.
    Cancer Res; 1983 Aug; 43(8):3493-6. PubMed ID: 6190553
    [Abstract] [Full Text] [Related]

  • 6. Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice.
    Veselý J, Cihák A.
    Cancer Res; 1977 Oct; 37(10):3684-9. PubMed ID: 71199
    [Abstract] [Full Text] [Related]

  • 7. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
    Balzarini J, De Clercq E.
    Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
    [Abstract] [Full Text] [Related]

  • 8. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
    Brockman RW, Shaddix SC, Williams M, Nelson JA, Rose LM, Schabel FM.
    Ann N Y Acad Sci; 1975 Aug 08; 255():501-21. PubMed ID: 171997
    [Abstract] [Full Text] [Related]

  • 9. In vitro cytotoxic and biochemical effects of 5-aza-2'-deoxycytidine.
    Momparler RL, Goodman J.
    Cancer Res; 1977 Jun 08; 37(6):1636-9. PubMed ID: 66984
    [Abstract] [Full Text] [Related]

  • 10. Modulation of deoxycytidine metabolism in vivo with high-dose thymidine in mice.
    Zaharko DS, Covey JM.
    J Natl Cancer Inst; 1983 Nov 08; 71(5):1033-9. PubMed ID: 6580479
    [Abstract] [Full Text] [Related]

  • 11. Dose- and schedule-dependent activation and drug synergism between thymidine and 5-aza-2'-deoxycytidine in a human promyelocytic leukemia cell line.
    Grant S, Rauscher F, Margolin J, Cadman E.
    Cancer Res; 1982 Feb 08; 42(2):519-24. PubMed ID: 6173114
    [Abstract] [Full Text] [Related]

  • 12. Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cells.
    Chabot GG, Momparler RL.
    Leuk Res; 1986 Feb 08; 10(5):533-7. PubMed ID: 2423812
    [Abstract] [Full Text] [Related]

  • 13. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
    Zaharko DS, Ramonas LM.
    J Natl Cancer Inst; 1982 May 08; 68(5):875-80. PubMed ID: 6951095
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxic and biochemical effects of thymidine and 3-deazauridine on human tumor cells.
    Lockshin A, Mendoza JT, Giovanella BC, Stehlin JS.
    Cancer Res; 1984 Jun 08; 44(6):2534-9. PubMed ID: 6722792
    [Abstract] [Full Text] [Related]

  • 15. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J, Cooney DA, Dalal M, Kang GJ, Cupp JE, DeClercq E, Broder S, Johns DG.
    Mol Pharmacol; 1987 Dec 08; 32(6):798-806. PubMed ID: 2826994
    [Abstract] [Full Text] [Related]

  • 16. Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
    De Clercq E, Balzarini J, Descamps J, Huang GF, Torrence PF, Bergstrom DE, Jones AS, Serafinowski P, Verhelst G, Walker RT.
    Mol Pharmacol; 1982 Jan 08; 21(1):217-23. PubMed ID: 7132959
    [Abstract] [Full Text] [Related]

  • 17. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA, Boothman DA, Perez LM, Greer S.
    Cancer Res; 1984 Jun 08; 44(6):2551-60. PubMed ID: 6539164
    [Abstract] [Full Text] [Related]

  • 18. Effects of the alpha-D-anomer of 5-aza-2'-deoxycytidine on L1210 mouse leukemic cells in vitro and in vivo.
    Veselý J, Pískala A.
    Cancer Res; 1984 Nov 08; 44(11):5165-8. PubMed ID: 6207913
    [Abstract] [Full Text] [Related]

  • 19. Biological characterization of a prolonged antileukemic effect of 5-azacytidine.
    Presant CA, Valeriote F, Vietti TJ.
    Cancer Res; 1977 Feb 08; 37(2):376-81. PubMed ID: 64294
    [Abstract] [Full Text] [Related]

  • 20. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM, Rustum YM.
    Cancer Res; 1985 Dec 08; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.